NEWTON, MA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)NATIONAL BRAIN TUMOR SOCIETY INC, founded in 1989, is a mid-sized nonprofit that reported $13.2M in total revenue in fiscal year 2024. Expenses of $12.6M left a modest 5% surplus.
NATIONAL BRAIN TUMOR SOCIETY UNRELENTINGLY INVESTS IN, MOBILIZES, ANDUNITES OUR COMMUNITY TO DISCOVER A CURE, DELIVER EFFECTIVE TREATMENTS,AND ADVOCATE FOR PATIENTS AND CARE PARTNERS.
OUR DEFEAT STRATEGY DRIVES AND INFLUENCES BEST-IN-CLASS MEDICAL RESEARCH TO DEVELOP AND DELIVER NEW INNOVATIVE TREATMENTS AND POTENTIAL CURES TO PATIENTS WITH BRAIN TUMORS AS QUICKLY AS POSSIBLE...
OUR DEFEAT STRATEGY DRIVES AND INFLUENCES BEST-IN-CLASS MEDICAL RESEARCH TO DEVELOP AND DELIVER NEW INNOVATIVE TREATMENTS AND POTENTIAL CURES TO PATIENTS WITH BRAIN TUMORS AS QUICKLY AS POSSIBLE. PATIENTS AND CAREGIVERS ARE OUR PRIORITY. WE FOCUS ON GROUNDBREAKING RESEARCH INITIATIVES WITH THE POTENTIAL TO TRANSLATE PROMISING SCIENCE FROM THE LAB INTO TREATMENTS THAT IMPROVE SURVIVAL AND QUALITY OF LIFE. WE'RE ACCELERATING BREAKTHROUGHS THAT WILL HAVE A PROFOUND IMPACT ON THE BRAIN TUMOR COMMUNITY. OUR RESEARCH INITIATIVES ADVANCE TREATMENTS FOR PATIENTS OF ALL AGES ACROSS BRAIN TUMOR TYPES. WE INCENTIVIZE AND FACILITATE COLLABORATION BETWEEN PHARMACEUTICAL COMPANIES, INVESTORS, AND WORLD-CLASS SCIENTISTS TO GET RESULTS FOR PATIENTS.
OUR CONNECT STRATEGY CONVENES, EDUCATES, AND UNITES THE BRAIN TUMOR COMMUNITY. WE BRING STAKEHOLDERS TOGETHER, TO ADDRESS BARRIERS TO THE DEVELOPMENT OF NEW TREATMENTS AND BETTER HEALTH CARE. NBTS...
OUR CONNECT STRATEGY CONVENES, EDUCATES, AND UNITES THE BRAIN TUMOR COMMUNITY. WE BRING STAKEHOLDERS TOGETHER, TO ADDRESS BARRIERS TO THE DEVELOPMENT OF NEW TREATMENTS AND BETTER HEALTH CARE. NBTS LEADS SEVERAL NATIONAL AWARENESS CAMPAIGNS TO EDUCATE THE PUBLIC ABOUT BRAIN TUMORS AND THE IMPORTANCE OF REDUCING THE BURDEN OF THEM. WE EQUIP PATIENTS AND CARE PARTNERS WITH TOOLS AND RESOURCES TO NAVIGATE EVERY STEP OF THEIR UNIQUE HEALTH CARE JOURNEYFROM UNDERSTANDING THEIR DIAGNOSIS AND BUILDING THEIR MEDICAL TEAM TO MAKING DECISIONS ABOUT TREATMENT. WE ORGANIZE EVENTS THAT BRING THE BRAIN TUMOR COMMUNITY TOGETHER TO HONOR, LEARN, DEVELOP MEANINGFUL RELATIONSHIPS, TURN GRIEF INTO ACTION, AND FUEL MOMENTUM FOR OUR CAUSE. OUR SUPPORT GROUPS FOSTER CONNECTIONS SHOWING PATIENTS AND CARE PARTNERS THAT THEY ARE NOT ALONE.
OUR CHANGE STRATEGY FUELS THE VOICE OF THE BRAIN TUMOR COMMUNITY TO ADVOCATE PUBLIC POLICY. WE ENSURE THE COMMUNITY'S NEEDS ARE REFLECTED IN NATIONAL MEDICAL RESEARCH AND HEALTH CARE POLICY...
OUR CHANGE STRATEGY FUELS THE VOICE OF THE BRAIN TUMOR COMMUNITY TO ADVOCATE PUBLIC POLICY. WE ENSURE THE COMMUNITY'S NEEDS ARE REFLECTED IN NATIONAL MEDICAL RESEARCH AND HEALTH CARE POLICY. TOGETHER, WE ADVOCATE FOR THE FEDERAL GOVERNMENT TO MAKE STRATEGIC INVESTMENTS IN BRAIN TUMOR RESEARCH, IMPROVE HEALTH CARE DELIVERY, REDUCE HEALTH DISPARITIES, AND RAISE THE PRIORITY LEVEL FOR OUR COMMUNITY'S NEEDS. OVER 18,000 VOLUNTEER ADVOCATES ACROSS ALL 50 STATES AFFECT CHANGE AT ALL LEVELS ANNUALLY. WE MOBILIZE OUR COMMUNITY ON POLICY ISSUES TO URGE GOVERNMENT OFFICIALS TO ENACT POLICIES THAT SUPPORT OUR VISION OF CONQUERING AND CURING BRAIN TUMORSONCE AND FOR ALL. THROUGH OUR ADVOCACY, WE AFFECT THE LIVES OF NEARLY ONE MILLION AMERICANS LIVING WITH A BRAIN TUMOR TODAY, AND THOSE WHO WILL BE DIAGNOSED.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $13,202,037 | $13,349,365 | 0.0% |
| Expenses | $12,600,569 | $12,250,340 | +0.0% |
| Net Income | $601,468 | $1,099,025 | -0.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| EDJAH NDUOM | CHAIR | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| ERICA BIRKE | VICE CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| MIL PAREKH | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| LEAH RECHT JD | CLERK | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| RYAN LANG | BOARD MEMBER (UNTIL 9/24) | 1.00 |
Director
|
$0 | $0 | $0 |
| ALLISON BISHOF | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| DR JOOHEE SUL | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| CORIE YUTKIN | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| ADAM HAYDEN | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| KABIR SETHI | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| FRANK MACCHIAROLA | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| CHRIS BROWN | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| KAREN TURNER | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| JONATHAN WEINBERG | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| JIGAR RAYTHATHA | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| DAVID ARONS | CEO | 40.00 |
Officer
|
$300,444 | $43,616 | $344,060 |
| MARISA PETRILLO | CHIEF PEOPLE OFFICER | 40.00 |
Officer
|
$162,556 | $33,895 | $196,451 |
| KATIE GERMAIN | CHIEF OF MARKETING & COMMUNICATIONS OFFICER | 40.00 |
Officer
|
$176,480 | $7,767 | $184,247 |
| RICHARD LESCARBEAU | VP OF FINANCE (AS OF 3/24) | 40.00 |
Officer
|
$143,208 | $36,667 | $179,875 |
| DOROTHY WHALEN | CHIEF FINANCIAL OFFICER (UNTIL 6/24) | 40.00 |
Officer
|
$98,561 | $10,946 | $109,507 |
| ASHLEY BRENNAN | VICE PRESIDENT, DEVELOPMENT | 40.00 |
Key Emp
|
$220,534 | $34,269 | $254,803 |
| KIRK TANNER | CHIEF SCIENTIFIC OFFICER | 40.00 |
Key Emp
|
$234,411 | $19,201 | $253,612 |
| JOHN HIGGINS | MANAGING DIRECTOR, BTIF | 40.00 |
Highest
|
$216,980 | $26,471 | $243,451 |
| ELIZABETH RYU | DIRECTOR OF RESEARCH | 40.00 |
Highest
|
$148,416 | $22,827 | $171,243 |
| GARY HEIMBERG | VP AND COUNSEL, GOVERNMENT RELATIONS | 40.00 |
Highest
|
$130,056 | $19,443 | $149,499 |
| ANNE STAMESHKIN | SENIOR DIRECTOR OF COMMUNICATIONS | 40.00 |
Highest
|
$137,160 | $8,520 | $145,680 |
| NOEL TWIGG | SENIOR DIRECTOR OF DEVELOPMENT | 40.00 |
Highest
|
$127,953 | $17,289 | $145,242 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $13,202,037 | $12,600,569 | $17,010,470 | $601,468 |
| 2023 | $13,349,365 | $12,250,340 | $15,961,971 | $1,099,025 |
| 2022 | $13,224,585 | $10,400,422 | $15,423,168 | $2,824,163 |
| 2021 | $11,776,482 | $8,948,424 | $13,088,308 | $2,828,058 |
| 2020 | $8,931,225 | $7,153,205 | $10,033,142 | $1,778,020 |
| 2019 | $14,164,709 | $9,637,844 | $7,787,968 | $4,526,865 |
| 2018 | $10,033,247 | $9,001,032 | $3,968,943 | $1,032,215 |
Compare NATIONAL BRAIN TUMOR SOCIETY INC with other nonprofits in Massachusetts and across the country.